Fujifilm Irvine Scientific launches insect cell media for viral vectors

By Ben Hargreaves contact

- Last updated on GMT

(Image: Getty/Marchmeena29)
(Image: Getty/Marchmeena29)

Related tags: Fujifilm Irvine Scientific, Cell culture media

Fujifilm Irvine Scientific announces low hydrolysate medium for use in insect cell expression systems.

The IS Sf Insect medium is a low hydrolysate medium that Fujifilm Irvine Scientific has developed for insect cell expressions expression systems.

The cell culture media can be used with Sf9 and Sf21 insect cells in suspension cultures, and supports baculovirus expression vector systems for protein expression, such as recombinant proteins and viral vector production.

Fujifilm Irvine Scientific states that its product offers advantages over yeast hydrolysate as a nutritional supplement due to more consistent growth and protein yield.

The industry is showing greater interest in using insect cells as production hosts for recombinant proteins and viral vectors because of their ability to produce large quantities of proteins and ability to adapt to high-density culture, according to a company spokesperson.

“However, the current practice of using undefined serum and high concentrations of hydrolysates as supplements results in significant variability between media lots and production runs,”​ said Robert Newman, CSO at Fujifilm Irvine Scientific.

The offering from Fujifilm Irvine Scientific arrives as more contract development and manufacturing organisations (CDMOs) look into investing away from mammalian cell lines and into alternatives​.

According to a spokesperson for the company, the global demand for cell culture media, used in cell line production, is growing by approximately 10% annually.

As a result of this market growth, Fujifilm acquired Irvine Scientific​ last year for $800m (€712m) to acquire its portfolio of cell culture media, reproductive technology, cytogenetics and regenerative medicines.

Related news

Show more

Related products

Connectivity & Integration in Biomanufacturing

Connectivity & Integration in Biomanufacturing

Wheeler Bio | 17-Nov-2022 | Technical / White Paper

As the Pharma 4.0 initiative sets a new industry paradigm, more biomanufacturing companies are asking how they can design and build facilities that apply...

Scalability, Quality, and Speed with Transposons

Scalability, Quality, and Speed with Transposons

Wheeler Bio | 20-Oct-2022 | Technical / White Paper

To solve for the significant bottlenecks often presented by conventional cell line development processes, this article discusses how Wheeler Bio is leveraging...

Accelerating Time to IND with Pharma 4.0

Accelerating Time to IND with Pharma 4.0

Wheeler Bio | 22-Sep-2022 | Technical / White Paper

The future of the biopharmaceutical industry hinges on its adoption of 21st-century digital tools and automation.

Discover the world of upstream bioprocessing

Discover the world of upstream bioprocessing

Eppendorf Bioprocess Solutions | 07-Sep-2022 | Technical / White Paper

A must-read for all bioprocess scientists: This bundle of four ebooks created by Eppendorf guides you through the world of upstream bioprocessing.

Related suppliers

Follow us


View more